Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA

Spiriva Respimat (tiotropium) will be the first long-acting anticholinergic for ASTHMA. It won't just be for COPD anymore.

But don't expect to see it used in too many asthma patients.

Explain that adding Spiriva to a high-dose inhaled steroid PLUS a long-acting beta-agonist (salmeterol, etc) seems to reduce asthma exacerbations.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote